These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8103583)

  • 1. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia.
    Steinberg GK; Panahian N; Pérez-Pinzón MA; Sun GH; Modi MW; Sepinwall J
    Neurobiol Dis; 1995 Apr; 2(2):109-18. PubMed ID: 8980014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC; Britton P; Williams A; Lu XC; Newman AH
    J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; Saleh J; DeLaPaz R; Kunis D; Zarnegar SR
    Brain Res; 1989 Sep; 497(2):382-6. PubMed ID: 2684345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia.
    Lo EH; Steinberg GK
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):803-9. PubMed ID: 1874811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
    McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
    Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury.
    Golding EM; Vink R
    Mol Chem Neuropathol; 1995; 24(2-3):137-50. PubMed ID: 7632318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis.
    Sellner J; Ringer R; Baumann P; Perey MJ; Schmitt B; Leib SL
    Curr Drug Metab; 2008 Jan; 9(1):83-8. PubMed ID: 18220575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.
    Pérez-Pinzón MA; Maier CM; Yoon EJ; Sun GH; Giffard RG; Steinberg GK
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):865-76. PubMed ID: 7673380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach.
    Block F; Schwarz M
    Neuroscience; 1998 Feb; 82(3):791-803. PubMed ID: 9483536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.